scholarly journals Identification of Cell Surface Antigen Expression in Canine Hepatocellular Carcinoma Cell Lines

2013 ◽  
pp. 831-835 ◽  
Author(s):  
Ayumi FUJIMOTO ◽  
Sakurako NEO ◽  
Chinatsu ISHIZUKA ◽  
Takashi KATO ◽  
Kazuhito SEGAWA ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Surface ◽  
Cell Lines ◽  
Surface Antigen ◽  
Carcinoma Cell ◽  
Antigen Expression ◽  
Cell Surface Antigen ◽  
Carcinoma Cell Lines ◽  
Surface Antigen Expression ◽  
Hepatocellular Carcinoma Cell

Expression of the cell surface antigen detected by the monoclonal antibody A7 in pancreatic carcinoma cell lines

Surgery Today ◽  
1992 ◽  
Vol 22 (4) ◽  
pp. 351-356 ◽  
Author(s):  
Eigo Otsuji ◽  
Toshiharu Yamaguchi ◽  
Nozomi Yamaguchi ◽  
Kunihiko Koyama ◽  
Jiro Imanishi ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Cell Surface ◽  
Pancreatic Carcinoma ◽  
Cell Lines ◽  
Surface Antigen ◽  
Carcinoma Cell ◽  
Cell Surface Antigen ◽  
Carcinoma Cell Lines ◽  
Monoclonal Antibody A7

scholarly journals NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway

2021 ◽  
Vol 20 ◽  
pp. 153303382110279
Author(s):  
SiZhe Yu ◽  
Yu Wang ◽  
KeJia Lv ◽  
Jia Hou ◽  
WenYuan Li ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Lines ◽  
Lung Metastasis ◽  
Carcinoma Cell ◽  
Binding Protein ◽  
Signal Transducer ◽  
Activation Domain ◽  
Carcinoma Cell Lines ◽  
Hepatocellular Carcinoma Cell ◽  
Transcription 3

Purpose: The high fatality-to-case ratio of hepatocellular carcinoma is directly related to metastasis. The signal transducer and activator of transcription-3 is a key mediator of the cytokine and growth factor signaling pathways and drives the transcription of genes responsible for cancer-associated phenotypes. However, so far, no specific inhibitor for signal transducer and activator of transcription-3 has been used in clinical practice. Therefore, targeting the signal transducer and activator of transcription-3 for cancer therapy is highly desired to improve outcomes in patients with hepatocellular carcinoma. Experimental Design: Using the small-molecule inhibitor NT157, the effect of signal transducer and activator of transcription-3 inhibition on cell migration was tested in hepatocellular carcinoma cell lines and a lung metastasis model of the disease. Results: NT157 significantly inhibited the migration of hepatocellular carcinoma cell lines in vitro and lung metastasis of hepatocellular carcinoma in vivo. Mechanistically, it inhibited the phospho-signal transducer and activator of transcription-3 in a dose- and time-dependent manner. Furthermore, NT157 treatment suppressed the c-Jun activation domain-binding protein-1 levels in the nucleus but no significant decrease was observed in its expression in the cytoplasm. Finally, high mRNA expression levels of signal transducer and activator of transcription-3 and c-Jun activation domain-binding protein-1 in hepatocellular carcinoma were associated with significantly low survival rates. Conclusion: NT157 inhibits hepatocellular carcinoma migration and metastasis by downregulating the signal transducer and activator of transcription-3/c-Jun activation domain-binding protein-1 signaling pathway and targeting it may serve as a novel therapeutic strategy for the clinical management of hepatocellular carcinoma in the future.

Sign in / Sign up

Export Citation Format

Share Document